RECURRENT DIFFUSE INTRINSIC PONTINE GLIOMA
Clinical trials for RECURRENT DIFFUSE INTRINSIC PONTINE GLIOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT DIFFUSE INTRINSIC PONTINE GLIOMA trials appear
Sign up with your email to follow new studies for RECURRENT DIFFUSE INTRINSIC PONTINE GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with deadly brain tumors: adaptive trial tests drug combos
Disease control Recruiting nowThis study is for children and young adults with diffuse midline gliomas (DMGs), including DIPG, a rare and aggressive brain tumor. The trial tests whether combining the drug ONC201 with other new agents can help control the disease. About 360 participants will receive different …
Matched conditions: RECURRENT DIFFUSE INTRINSIC PONTINE GLIOMA
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 26, 2026 03:38 UTC
-
New hope for kids with tough brain tumors: targeted radiation drug enters trial
Disease control Recruiting nowThis study tests a drug called Lutathera in children and young adults (ages 4 to 39) whose brain tumors have come back or are growing despite treatment. The drug delivers radiation directly to tumor cells that show up on a special PET scan. The goal is to find the safest dose and…
Matched conditions: RECURRENT DIFFUSE INTRINSIC PONTINE GLIOMA
Phase: PHASE1, PHASE2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated May 26, 2026 03:33 UTC
-
New hope for kids with relapsed cancers: CBL0137 trial launches
Disease control Recruiting nowThis study tests a drug called CBL0137 in children and young adults (ages 1 to 21) whose solid tumors, brain tumors, or lymphoma have returned or stopped responding to treatment. The goal is to find the safest dose and see if the drug can shrink tumors by blocking signals that he…
Matched conditions: RECURRENT DIFFUSE INTRINSIC PONTINE GLIOMA
Phase: PHASE1, PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 26, 2026 02:48 UTC